---
title: "Your Patents Are Worth Cash Right Now. Stop Diluting Yourself to Get It."
slug: ip-backed-lending-patents-as-collateral
date: 2026-04-07
url: https://beyondelevation.com/blog/post.html?slug=ip-backed-lending-patents-as-collateral
author: Hayat Amin
site: Beyond Elevation
---

# Your Patents Are Worth Cash Right Now. Stop Diluting Yourself to Get It.

A founder I know raised a $4M Series A last year. Gave up 22% of his company to do it. Six months later he found out he could have borrowed $2.5M against his patent portfolio at 9% interest and kept every share. He did not know IP-backed lending existed. Neither do most founders. That ignorance cost him roughly $18M in diluted equity at his projected Series B valuation.

This is not a niche financing trick. The global IP-backed lending market hit $5.2 billion in 2025. Banks, specialty lenders, and sovereign funds are actively lending against patent portfolios, and the founders who understand this have a capital advantage that everyone else is sleeping on.

## What Is IP-Backed Lending and How Does It Work?

IP-backed lending is a financing structure where a company uses its intellectual property — patents, patent portfolios, or other registered IP — as collateral to secure a loan. Beyond Elevation works with tech and AI founders to structure these deals because they represent one of the fastest paths to non-dilutive capital available today.

Here is the simple version. You own patents. A lender appraises those patents. They lend you 15–35% of the appraised value at interest rates typically between 8% and 14%. You keep your equity. You keep your cap table clean. You get cash.

Compare that to a priced equity round where you hand over 15–25% of your company. The math is not subtle.

## Why Are Lenders Willing to Accept Patents as Collateral?

Because patents are legally enforceable assets with quantifiable market value. This is not theory. In 2024, patent transactions exceeded $8.1 billion globally. There is a liquid secondary market for IP. Lenders know that if you default, they can sell or license your portfolio to recover their capital.

Three things make a patent portfolio attractive to lenders:

One — breadth. A portfolio of 10–15 related patents across a technology stack is more lendable than a single patent. Lenders want diversified collateral, same as any other asset class.

Two — active licensing revenue. If your patents already generate licensing income, you are not asking a lender to speculate. You are showing them a cash-flowing asset. Beyond Elevation helped Position Imaging restructure 66 patents specifically to increase both licensing revenue and collateral value.

Three — remaining term. Patents with 10+ years of remaining life are worth more as collateral than patents expiring in three years. This is basic duration math.

## How Much Can You Actually Borrow Against a Patent Portfolio?

Typical loan-to-value ratios for IP-backed lending sit between 15% and 35% of the appraised portfolio value. That number moves based on the quality of your IP, whether it generates revenue, and the lender's risk appetite.

Here is a real-world frame. If your patent portfolio is independently valued at $20M, you can reasonably expect to borrow $3M to $7M. If those patents are already producing licensing revenue, that number pushes toward the higher end. If they are unmonetised but defensible, you are looking at the lower end.

For context: a typical VC round at that stage would cost you 20% of your company. At a $50M pre-money valuation, that is $10M in equity gone. A $5M IP-backed loan at 11% interest costs you $550K per year in interest. That is the entire comparison. Equity that costs you millions in ownership versus debt that costs you thousands in interest.

## Who Offers IP-Backed Loans?

The market has matured significantly in the last three years. Specialty IP lenders like Aon, WN Intellectual Property, and Fortress Investment Group have dedicated IP lending desks. Several commercial banks — particularly in the UK, Singapore, and South Korea — now accept IP as collateral under government-backed schemes. The UK Intellectual Property Office ran a £1.2 billion IP-backed lending pilot that proved the model works at scale.

South Korea's IP financing programme has issued over $3 billion in IP-collateralised loans since 2014. Singapore's IPOS runs an IP financing scheme specifically for tech companies. This is not experimental. Governments are building infrastructure around it because they see the data.

## What Do You Need Before Approaching an IP-Backed Lender?

Four things. Miss any one of them and you are wasting everyone's time.

First — a formal IP valuation from a recognised firm. Not your internal estimate. Not what your patent attorney thinks it might be worth. A third-party valuation using accepted methodologies: income approach, market approach, or cost approach. Beyond Elevation structures these valuations specifically for lending contexts, because the framing matters as much as the number.

Second — a clean chain of title. Every patent must be properly assigned to the borrowing entity. Lenders will walk if there are assignment gaps, co-ownership disputes, or unclear inventor agreements. This is basic IP hygiene that most startups get wrong.

Third — documentation of the portfolio's commercial relevance. Lenders want to see that your patents map to real products, real markets, and real competitors who would need to license if they wanted to compete. A patent on technology nobody uses is not collateral. It is wallpaper.

Fourth — evidence of enforceability. Your patents need to have survived prior art scrutiny. If a lender's diligence team finds obvious invalidity risks, your loan-to-value ratio drops to zero.

## Can AI Companies Use IP-Backed Lending?

Yes — and they should be first in line. AI companies sit on some of the most valuable and fastest-appreciating patent portfolios in the market. The number of AI-related patent filings grew 38% year-over-year in 2025. Lenders are actively seeking AI patent collateral because the secondary market demand is enormous.

But there is a catch. Most AI founders have not structured their IP for lendability. They have a handful of patents filed reactively, covering narrow implementations rather than broad technology claims. That is the difference between a portfolio a lender values at $5M and one they value at $25M. The underlying technology might be identical. The structuring is what moves the number.

Beyond Elevation's work with DGS on data monetisation illustrates this exactly. The same underlying data assets, restructured and properly valued, became a revenue-generating portfolio. The same principle applies to patent collateral. Structure determines value.

## What Are the Risks of IP-Backed Lending?

The obvious one: if you default, you lose your patents. That is real. If your IP is core to your product, losing it in a default scenario could be fatal to the business. This is not free money. It is debt secured by your most strategic assets.

The mitigation is straightforward. Do not borrow against patents that are essential to your current product if you cannot service the debt from operating cash flow. Borrow against adjacent patents, continuation patents, or portfolio segments that generate licensing revenue independent of your core product. This is portfolio architecture, and it is why working with an IP strategist before approaching a lender is not optional — it is the step that determines whether this tool helps you or kills you.

## How Does IP-Backed Lending Compare to Revenue-Based Financing?

Revenue-based financing requires revenue. IP-backed lending requires IP. For pre-revenue or early-revenue companies with strong patent portfolios, IP-backed lending unlocks capital that revenue-based models cannot touch.

A pre-revenue AI company with 12 granted patents and a clean valuation can borrow against those patents today. A revenue-based lender will not return their call until they have $1M+ ARR. That timing gap is where IP-backed lending wins.

For companies with both revenue and IP, the two stack. You can layer an IP-backed facility on top of revenue-based financing to maximise non-dilutive capital before touching equity. Every dollar of debt you can responsibly service is a dollar of equity you do not sell.

### FAQ

### What is the minimum patent portfolio size for IP-backed lending?

Most specialty lenders want to see a portfolio valued at $5M or more, which typically means 5–15 granted patents with clear commercial relevance. Single patents can sometimes qualify if they generate significant licensing revenue, but portfolio lending is the norm.

### How long does the IP-backed lending process take?

From initial approach to funded loan, expect 60–120 days. The bottleneck is almost always the IP valuation and due diligence phase. Having a current, third-party valuation ready before you approach a lender can cut that timeline in half.

### Does IP-backed lending affect my ability to raise equity later?

Not negatively — and often positively. Investors see IP-backed debt as a signal that your patents have independently verified value. It also means you raised capital without dilution, which means more ownership for everyone at the equity table. A clean IP-backed loan on your balance sheet is a feature, not a bug.

### Can I still license my patents while they are used as collateral?

Yes. Most IP-backed lending agreements explicitly allow continued licensing. In fact, lenders prefer it — licensing revenue increases the probability you can service the debt. The collateral interest attaches to the patent ownership, not the licensing income stream.

If you are sitting on a patent portfolio and your next instinct is to raise an equity round, stop. Get your IP valued. Explore what you can borrow against it first. The founders who figure this out keep 10–20% more of their company by the time they exit.

Beyond Elevation structures patent portfolios for maximum collateral value and connects founders with IP-backed lending partners. If you want to know what your patents are worth as collateral, start at [beyondelevation.com](https://beyondelevation.com).

---
*Published on [Beyond Elevation](https://beyondelevation.com) — IP Strategy & Licensing Revenue Consultancy*